vs
Side-by-side financial comparison of Foghorn Therapeutics Inc. (FHTX) and UNITED SECURITY BANCSHARES (UBFO). Click either name above to swap in a different company.
UNITED SECURITY BANCSHARES is the larger business by last-quarter revenue ($13.5M vs $9.2M, roughly 1.5× Foghorn Therapeutics Inc.). UNITED SECURITY BANCSHARES runs the higher net margin — 25.2% vs -234.3%, a 259.5% gap on every dollar of revenue. On growth, Foghorn Therapeutics Inc. posted the faster year-over-year revenue change (223.8% vs 13.6%). Over the past eight quarters, Foghorn Therapeutics Inc.'s revenue compounded faster (35.3% CAGR vs 3.0%).
Foghorn Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing novel therapies targeting the chromatin regulatory system to treat various types of cancer and other severe diseases. It advances a diverse pipeline of targeted drug candidates, conducting internal R&D and strategic partnerships to serve global patient populations.
United Security Bancshares is a bank holding company headquartered in Fresno, California. It operates 11 branches.
FHTX vs UBFO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $9.2M | $13.5M |
| Net Profit | $-21.7M | $3.4M |
| Gross Margin | — | — |
| Operating Margin | -258.2% | 31.5% |
| Net Margin | -234.3% | 25.2% |
| Revenue YoY | 223.8% | 13.6% |
| Net Profit YoY | -11.1% | 36.8% |
| EPS (diluted) | $-0.35 | $0.18 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $9.2M | $13.5M | ||
| Q3 25 | $8.2M | $14.0M | ||
| Q2 25 | $7.6M | $12.6M | ||
| Q1 25 | $6.0M | $13.7M | ||
| Q4 24 | $2.9M | $11.9M | ||
| Q3 24 | $7.8M | $13.8M | ||
| Q2 24 | $6.9M | $13.0M | ||
| Q1 24 | $5.0M | $12.8M |
| Q4 25 | $-21.7M | $3.4M | ||
| Q3 25 | $-15.8M | $4.0M | ||
| Q2 25 | $-17.9M | $2.2M | ||
| Q1 25 | $-18.8M | $2.7M | ||
| Q4 24 | $-19.5M | $2.5M | ||
| Q3 24 | $-19.1M | $3.8M | ||
| Q2 24 | $-23.0M | $4.3M | ||
| Q1 24 | $-25.0M | $4.2M |
| Q4 25 | -258.2% | 31.5% | ||
| Q3 25 | -226.9% | 40.3% | ||
| Q2 25 | -279.2% | 24.0% | ||
| Q1 25 | -385.0% | 27.5% | ||
| Q4 24 | -840.5% | 27.5% | ||
| Q3 24 | -305.5% | 37.1% | ||
| Q2 24 | -386.6% | 46.4% | ||
| Q1 24 | -558.3% | 45.9% |
| Q4 25 | -234.3% | 25.2% | ||
| Q3 25 | -194.4% | 28.7% | ||
| Q2 25 | -237.3% | 17.2% | ||
| Q1 25 | -316.4% | 19.6% | ||
| Q4 24 | -682.9% | 20.9% | ||
| Q3 24 | -244.9% | 27.7% | ||
| Q2 24 | -333.6% | 33.0% | ||
| Q1 24 | -495.4% | 32.6% |
| Q4 25 | $-0.35 | $0.18 | ||
| Q3 25 | $-0.25 | $0.23 | ||
| Q2 25 | $-0.28 | $0.13 | ||
| Q1 25 | $-0.30 | $0.16 | ||
| Q4 24 | $-0.23 | $0.14 | ||
| Q3 24 | $-0.31 | $0.22 | ||
| Q2 24 | $-0.45 | $0.25 | ||
| Q1 24 | $-0.59 | $0.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $80.9M | $264.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-108.5M | $139.7M |
| Total Assets | $198.1M | $1.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $80.9M | $264.2M | ||
| Q3 25 | $89.3M | $211.1M | ||
| Q2 25 | $72.6M | $199.5M | ||
| Q1 25 | $61.0M | $198.4M | ||
| Q4 24 | $55.5M | $216.9M | ||
| Q3 24 | $57.7M | $216.8M | ||
| Q2 24 | $138.9M | $166.3M | ||
| Q1 24 | $79.3M | $168.6M |
| Q4 25 | $-108.5M | $139.7M | ||
| Q3 25 | $-89.7M | $137.4M | ||
| Q2 25 | $-76.7M | $134.3M | ||
| Q1 25 | $-61.7M | $132.9M | ||
| Q4 24 | $-45.5M | $130.4M | ||
| Q3 24 | $-28.3M | $132.9M | ||
| Q2 24 | $-14.3M | $127.3M | ||
| Q1 24 | $-97.5M | $124.2M |
| Q4 25 | $198.1M | $1.2B | ||
| Q3 25 | $205.0M | $1.2B | ||
| Q2 25 | $226.2M | $1.2B | ||
| Q1 25 | $258.7M | $1.2B | ||
| Q4 24 | $284.0M | $1.2B | ||
| Q3 24 | $308.4M | $1.3B | ||
| Q2 24 | $328.6M | $1.2B | ||
| Q1 24 | $255.0M | $1.2B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-22.3M | $22.1M |
| Free Cash FlowOCF − Capex | — | $19.8M |
| FCF MarginFCF / Revenue | — | 146.0% |
| Capex IntensityCapex / Revenue | 0.0% | 16.8% |
| Cash ConversionOCF / Net Profit | — | 6.46× |
| TTM Free Cash FlowTrailing 4 quarters | — | $36.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-22.3M | $22.1M | ||
| Q3 25 | $-18.9M | $7.0M | ||
| Q2 25 | $-21.0M | $8.7M | ||
| Q1 25 | $-24.0M | $3.0M | ||
| Q4 24 | $-24.5M | $19.6M | ||
| Q3 24 | $-21.0M | $5.4M | ||
| Q2 24 | $-25.5M | $2.3M | ||
| Q1 24 | $-29.3M | $7.4M |
| Q4 25 | — | $19.8M | ||
| Q3 25 | — | $6.1M | ||
| Q2 25 | $-21.0M | $8.1M | ||
| Q1 25 | $-24.0M | $2.9M | ||
| Q4 24 | $-25.0M | $18.6M | ||
| Q3 24 | $-21.3M | $5.3M | ||
| Q2 24 | $-25.6M | $2.0M | ||
| Q1 24 | $-29.4M | $7.0M |
| Q4 25 | — | 146.0% | ||
| Q3 25 | — | 43.7% | ||
| Q2 25 | -278.2% | 64.3% | ||
| Q1 25 | -403.2% | 21.2% | ||
| Q4 24 | -875.3% | 156.0% | ||
| Q3 24 | -273.0% | 38.1% | ||
| Q2 24 | -371.0% | 15.5% | ||
| Q1 24 | -583.1% | 54.8% |
| Q4 25 | 0.0% | 16.8% | ||
| Q3 25 | 0.0% | 6.0% | ||
| Q2 25 | 0.3% | 4.6% | ||
| Q1 25 | 0.5% | 0.9% | ||
| Q4 24 | 16.8% | 8.7% | ||
| Q3 24 | 4.0% | 0.7% | ||
| Q2 24 | 0.2% | 2.2% | ||
| Q1 24 | 2.0% | 3.6% |
| Q4 25 | — | 6.46× | ||
| Q3 25 | — | 1.73× | ||
| Q2 25 | — | 4.01× | ||
| Q1 25 | — | 1.13× | ||
| Q4 24 | — | 7.87× | ||
| Q3 24 | — | 1.40× | ||
| Q2 24 | — | 0.54× | ||
| Q1 24 | — | 1.79× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
